Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Real-life validation of the Panbio COVID-19 Antigen Rapid Test (Abbott) in community-dwelling subjects with symptoms of potential SARS-CoV-2 infection

View ORCID ProfileHendrik Gremmels, View ORCID ProfileBeatrice M.F. Winkel, View ORCID ProfileRob Schuurman, Andert Rosingh, Nicolette A.M. Rigter, Olga Rodriguez, Johan Ubijaan, Annemarie M.J. Wensing, View ORCID ProfileMarc J.M. Bonten, View ORCID ProfileL.Marije Hofstra
doi: https://doi.org/10.1101/2020.10.16.20214189
Hendrik Gremmels
1University Medical Center Utrecht, Department of Medical Microbiology, Heidelberglaan 100, 3584 CX, Utrecht, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Hendrik Gremmels
Beatrice M.F. Winkel
1University Medical Center Utrecht, Department of Medical Microbiology, Heidelberglaan 100, 3584 CX, Utrecht, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Beatrice M.F. Winkel
Rob Schuurman
1University Medical Center Utrecht, Department of Medical Microbiology, Heidelberglaan 100, 3584 CX, Utrecht, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Rob Schuurman
Andert Rosingh
2LABHOH, Fundacion Servicio Medico Laboratorio Aruba, Dr. Horacio E. Oduber Hospital, Boulevard 1, Oranjestad Aruba
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nicolette A.M. Rigter
3GGD regio Utrecht, De Dreef 5, 3706 BR Zeist
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Olga Rodriguez
4Dr. Horacio E. Oduber Hospital, Boulevard 1, Oranjestad Aruba
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Johan Ubijaan
2LABHOH, Fundacion Servicio Medico Laboratorio Aruba, Dr. Horacio E. Oduber Hospital, Boulevard 1, Oranjestad Aruba
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Annemarie M.J. Wensing
1University Medical Center Utrecht, Department of Medical Microbiology, Heidelberglaan 100, 3584 CX, Utrecht, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marc J.M. Bonten
1University Medical Center Utrecht, Department of Medical Microbiology, Heidelberglaan 100, 3584 CX, Utrecht, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Marc J.M. Bonten
L.Marije Hofstra
1University Medical Center Utrecht, Department of Medical Microbiology, Heidelberglaan 100, 3584 CX, Utrecht, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for L.Marije Hofstra
  • For correspondence: L.M.Hofstra-4@umcutrecht.nl
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Background RT-qPCR is the reference test for identification of active SARS-CoV-2 infection, but is associated with diagnostic delay. Antigen detection assays can generate results within 20 minutes and outside of laboratory settings. Yet, their diagnostic test performance in real life settings has not been determined.

Methods The diagnostic value of the Panbio™ COVID-19 Ag Rapid Test (Abbott), was determined in comparison to RT-qPCR (Seegene Allplex) in community-dwelling mildly symptomatic subjects in a medium (Utrecht, the Netherlands) and high endemic area (Aruba), using two concurrently obtained nasopharyngeal swabs.

Findings 1367 and 208 subjects were enrolled in Utrecht and Aruba, respectively. SARS-CoV-2 prevalence, based on RT-qPCR, was 10.2% (n=139) and 30.3% (n=63) in Utrecht and Aruba respectively. Specificity of the Panbio™ COVID-19 Ag Rapid Test was 100% (95%CI: 99.7-100%) in both settings. Test sensitivity was 72.6% (95%CI: 64.5-79.9%) in the Netherlands and 81.0% (95% CI: 69.0–89.8%) in Aruba. Probability of false negative results was associated with RT-qPCR Ct-values, but not with duration of symptoms. Restricting RT-qPCR test positivity to Ct-values <32 yielded test sensitivities of 95.2% (95%CI: 89.3-98.5%) in the Netherlands and 98.0% (95%CI: 89.2–99.95%) in Aruba.

Interpretation In community-dwelling subjects with mild respiratory symptoms the Panbio™ COVID-19 Ag Rapid Test had 100% specificity, and a sensitivity above 95% for nasopharyngeal samples when using Ct values <32 cycles as cut-off for RT-qPCR test positivity. Considering short turnaround times, user friendliness, low costs and opportunities for decentralized testing, this test can improve our efforts to control transmission of SARS-CoV-2.

Funding UMCU and LABHOH, Aruba

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This study was investigator initiated. No external funding was received.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The medical research ethics committee (MREC) of Utrecht decided the study is not subject to the Medical Research Involving Human Subjects Act (WMO) and did not require full review by an accredited MREC. The ethical committee of the hospital board of Aruba approved the study. All participants have provided written informed consent.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

All available deidentified participant data can be made available upon request per email to the corresponding author.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted October 20, 2020.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Real-life validation of the Panbio COVID-19 Antigen Rapid Test (Abbott) in community-dwelling subjects with symptoms of potential SARS-CoV-2 infection
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Real-life validation of the Panbio COVID-19 Antigen Rapid Test (Abbott) in community-dwelling subjects with symptoms of potential SARS-CoV-2 infection
Hendrik Gremmels, Beatrice M.F. Winkel, Rob Schuurman, Andert Rosingh, Nicolette A.M. Rigter, Olga Rodriguez, Johan Ubijaan, Annemarie M.J. Wensing, Marc J.M. Bonten, L.Marije Hofstra
medRxiv 2020.10.16.20214189; doi: https://doi.org/10.1101/2020.10.16.20214189
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Real-life validation of the Panbio COVID-19 Antigen Rapid Test (Abbott) in community-dwelling subjects with symptoms of potential SARS-CoV-2 infection
Hendrik Gremmels, Beatrice M.F. Winkel, Rob Schuurman, Andert Rosingh, Nicolette A.M. Rigter, Olga Rodriguez, Johan Ubijaan, Annemarie M.J. Wensing, Marc J.M. Bonten, L.Marije Hofstra
medRxiv 2020.10.16.20214189; doi: https://doi.org/10.1101/2020.10.16.20214189

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Public and Global Health
Subject Areas
All Articles
  • Addiction Medicine (269)
  • Allergy and Immunology (549)
  • Anesthesia (134)
  • Cardiovascular Medicine (1746)
  • Dentistry and Oral Medicine (238)
  • Dermatology (172)
  • Emergency Medicine (310)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (651)
  • Epidemiology (10770)
  • Forensic Medicine (8)
  • Gastroenterology (582)
  • Genetic and Genomic Medicine (2930)
  • Geriatric Medicine (286)
  • Health Economics (531)
  • Health Informatics (1917)
  • Health Policy (832)
  • Health Systems and Quality Improvement (741)
  • Hematology (290)
  • HIV/AIDS (627)
  • Infectious Diseases (except HIV/AIDS) (12495)
  • Intensive Care and Critical Care Medicine (684)
  • Medical Education (299)
  • Medical Ethics (86)
  • Nephrology (319)
  • Neurology (2778)
  • Nursing (150)
  • Nutrition (431)
  • Obstetrics and Gynecology (553)
  • Occupational and Environmental Health (596)
  • Oncology (1451)
  • Ophthalmology (440)
  • Orthopedics (172)
  • Otolaryngology (254)
  • Pain Medicine (190)
  • Palliative Medicine (56)
  • Pathology (378)
  • Pediatrics (863)
  • Pharmacology and Therapeutics (361)
  • Primary Care Research (333)
  • Psychiatry and Clinical Psychology (2626)
  • Public and Global Health (5336)
  • Radiology and Imaging (1001)
  • Rehabilitation Medicine and Physical Therapy (592)
  • Respiratory Medicine (721)
  • Rheumatology (329)
  • Sexual and Reproductive Health (288)
  • Sports Medicine (278)
  • Surgery (327)
  • Toxicology (47)
  • Transplantation (149)
  • Urology (124)